Dennis Panicali
- Immunology top 0.2%
- Virology top 0.1%
- Epidemiology top 1%
- Molecular Biology top 5%
- Oncology top 1%
- Co-authors
- Enzo PaolettiM. D. DanielPrabhat K. SehgalRonald C. DesrosiersD J RinglerKazuyasu MoriGail P. MazzaraJeffrey Schlom
- Topics
- Immunotherapy and Immune Responses (38 papers)HIV Research and Treatment (30 papers)Virus-based gene therapy research (28 papers)
- Partner nations
- United StatesGermanyNetherlands
In The Last Decade
Dennis Panicali
84 papers receiving 8.1k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Immunology 4.6k
- Virology 4.0k
- Epidemiology 2.2k
- Molecular Biology 2.0k
- Oncology 2.0k
Countries citing papers authored by Dennis Panicali
This map shows the geographic impact of Dennis Panicali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dennis Panicali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dennis Panicali more than expected).
Fields of papers citing papers by Dennis Panicali
This network shows the impact of papers produced by Dennis Panicali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dennis Panicali. The network helps show where Dennis Panicali may publish in the future.
Co-authorship network of co-authors of Dennis Panicali
This figure shows the co-authorship network connecting the top 25 collaborators of Dennis Panicali. A scholar is included among the top collaborators of Dennis Panicali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dennis Panicali. Dennis Panicali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 36 | |
| 2 | 29 | |
| 3 | The evolution of poxvirus based cancer vaccines | 1 |
| 4 | 22 | |
| 5 | 313 | |
| 6 | 3 | |
| 7 | 145 | |
| 8 | 93 | |
| 9 | 31 | |
| 10 | 61 | |
| 11 | 9 | |
| 12 | 53 | |
| 13 | 9 | |
| 14 | 5 | |
| 15 | 49 | |
| 16 | 17 | |
| 17 | 170 | |
| 18 | Analysis of c-erbB-2 expression in breast carcinomas with clinical follow-up. | 104 |
| 19 | Generation and characterization of monoclonal antibodies specific for the human neu oncogene product, p185. | 117 |
| 20 | 5 |
About Dennis Panicali
Dennis Panicali is a scholar working on Virology, Immunology and Genetics, having authored 84 papers that have together received 8.4k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (38 papers), HIV Research and Treatment (30 papers) and Virus-based gene therapy research (28 papers). The work is most often cited by research in Virology (4.0k citations), Immunology (4.6k citations) and Infectious Diseases (1.5k citations). Dennis Panicali has collaborated with scholars based in United States, Germany and Netherlands. Frequent co-authors include Enzo Paoletti, M. D. Daniel, Prabhat K. Sehgal, Ronald C. Desrosiers, D J Ringler, Kazuyasu Mori, Gail P. Mazzara, Jeffrey Schlom, Philip M. Arlen and James L. Gulley. Their work appears in journals such as Science, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.